Log in to search using one of your social media accounts:

 

ReoPro (Abciximab) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 3, 2017 Category: Drugs & Pharmacology Source Type: news

REOPRO (Abciximab) Injection, Solution [Janssen Biotech, Inc.]
Updated Date: Jan 3, 2017 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - January 3, 2017 Category: Drugs & Pharmacology Source Type: news

REOPRO (Abciximab) Injection, Solution [Eli Lilly And Company]
Updated Date: Aug 24, 2016 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - August 24, 2016 Category: Drugs & Pharmacology Source Type: news

Intracoronary Abciximab Better for Diabetics? (CME/CE)
(MedPage Today) -- Meta-analysis suggests big advantage, but some call it implausible (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - August 8, 2016 Category: Urology & Nephrology Source Type: news

ReoPro (Abciximab) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 9, 2014 Category: Drugs & Pharmacology Source Type: news

Intracoronary ReoPro No Help at 1 Year (CME/CE)
(MedPage Today) -- For patients with an acute ST-segment elevation MI (STEMI), intracoronary administration of abciximab (ReoPro) in the catheterization lab does not improve clinical outcomes, 1-year results of the AIDA STEMI trial confirmed. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 11, 2013 Category: Cardiology Source Type: news